2/27
08:08 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Low
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
2/27
05:19 am
tsha
Rating for TSHA
Low
Report
Rating for TSHA
2/27
05:19 am
tsha
Rating for TSHA
Low
Report
Rating for TSHA
2/26
05:55 pm
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
Low
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
2/26
05:47 pm
tsha
Rating for TSHA
Low
Report
Rating for TSHA
1/6
08:14 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Medium
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
1/6
06:40 am
tsha
Rating for TSHA
Medium
Report
Rating for TSHA
1/6
06:40 am
tsha
Rating for TSHA
Medium
Report
Rating for TSHA